India Education Diary on MSN
New clinical trial to compare the effectiveness of IV treatments for severe asthma in children
India, Jan. 24 -- A clinical trial to determine the best intravenous (IV) treatments for children with severe asthma will go ...
Omalizumab or dupilumab suggested for adults with moderate-to-severe allergic asthma, history of exacerbations requiring oral corticosteroids ...
Asthma is one of the most prevalent chronic inflammatory respiratory diseases across the globe, with a significant increase ...
A new study shows that internet-delivered cognitive behavioral therapy (ICBT) can effectively reduce asthma-related anxiety ...
The American College of Chest Physicians (CHEST) recently released a new clinical guideline on biologic management in severe ...
A 45-year-old woman presents with long-standing exertional dyspnea, wheezing, and intermittent dry cough, which has been ongoing for over the past 10 years.
The American College of Chest Physicians recently released a new clinical guideline on biologic management in severe asthma.
The American College of Chest Physicians released a new clinical guideline on biologic management in severe asthma containing seven evidence-based recommendations.
Dr. Marc Cromie with the Chattanooga Allergy Clinic joins News 12’s Chip Chapman at the start of the New Year with some health tips. CHATTANOOGA, Tenn. (WDEF) – Flu season is here but best not to ...
The US FDA has approved depemokimab as an add-on maintenance therapy for individuals aged 12 years or older with severe asthma, according to a press release from manufacturer GlaxoSmithKline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results